66 related articles for article (PubMed ID: 8833934)
1. [Frequency of HPV infection and level of glutathione in serum of women with cervix dysplasia].
Kwaśniewska A; Tukendorf A; Semczuk M
Med Dosw Mikrobiol; 1995; 47(3-4):213-8. PubMed ID: 8833934
[TBL] [Abstract][Full Text] [Related]
2. [Frequency of HPV infection and the level of ascorbic acid in serum of women with cervix dysplasia].
Kwaśniewska A; Tukendorf A; Semczuk M
Med Dosw Mikrobiol; 1996; 48(3-4):183-8. PubMed ID: 9182140
[TBL] [Abstract][Full Text] [Related]
3. Frequency of HPV infection and GSH levels in plasma of women with cervical dysplasia.
Kwaśniewska A; Tukendorf A; Semczuk M
Eur J Gynaecol Oncol; 1997; 18(3):196-9. PubMed ID: 9174835
[TBL] [Abstract][Full Text] [Related]
4. [Use of the Digene Hybrid Capture System for identification of the human papillomavirus (HPV-Human Papillomavirus) in women with cervical dysplasia].
Kwaśniewska A; Semczuk M; Sikorski M; Kraczkowski J
Przegl Lek; 1997; 54(12):848-50. PubMed ID: 9591452
[TBL] [Abstract][Full Text] [Related]
5. The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii.
Goodman MT; Kiviat N; McDuffie K; Hankin JH; Hernandez B; Wilkens LR; Franke A; Kuypers J; Kolonel LN; Nakamura J; Ing G; Branch B; Bertram CC; Kamemoto L; Sharma S; Killeen J
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):537-44. PubMed ID: 9641499
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of cytomorphological traits in low and high risk type HPV infections.
Korobowicz E; Kwaśniewska A; Georgiades I
Pol J Pathol; 1997; 48(2):107-12. PubMed ID: 9278107
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
Hankins C; Coutlée F; Lapointe N; Simard P; Tran T; Samson J; Hum L
CMAJ; 1999 Jan; 160(2):185-91. PubMed ID: 9951439
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
9. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?
Kjaer SK; van den Brule AJ; Bock JE; Poll PA; Engholm G; Sherman ME; Walboomers JM; Meijer CJ
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):799-805. PubMed ID: 9332762
[TBL] [Abstract][Full Text] [Related]
10. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
[TBL] [Abstract][Full Text] [Related]
12. [Biology of papillomavirus II infections. Their role in the carcinogenesis of the cervix].
Mougin C; Bernard B; Lab M
Ann Biol Clin (Paris); 1998; 56(1):21-8. PubMed ID: 9754219
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
[TBL] [Abstract][Full Text] [Related]
14. [The role of some micronutrients in the evolution of HPV infection].
Atlante M; Mariani L; Luci M; Carico E; Diotallevi F; Iacovelli A; Vincenzoni C
Minerva Ginecol; 2002 Apr; 54(2):179-83. PubMed ID: 12032456
[TBL] [Abstract][Full Text] [Related]
15. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
16. [Study of the association between human papillomavirus infection and cervical cancer in Xianguan county, Shanxi province].
Zhao F; Li N; Ma J
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Oct; 22(5):375-8. PubMed ID: 11769697
[TBL] [Abstract][Full Text] [Related]
17. High recurrence rate of cervical dysplasia and persistence of HPV infection in HIV-1-infected women.
Gingelmaier A; Grubert T; Kaestner R; Mylonas I; Weissenbacher T; Bergauer F; Barthell L; Friese K
Anticancer Res; 2007; 27(4A):1795-8. PubMed ID: 17649775
[TBL] [Abstract][Full Text] [Related]
18. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
[TBL] [Abstract][Full Text] [Related]
19. [Estimation of HPV infection presence in cytological smears in a group of asymptomatic women].
Łukaszuk K; Liss J; Zalewski J; Roter M; Brzóska B; Debniak J
Wiad Lek; 2001; 54(9-10):508-15. PubMed ID: 11816294
[TBL] [Abstract][Full Text] [Related]
20. [Frequency of HPV infection of the uterine cervix among perimenopausal women in Wielkopolska Region].
Zietkowiak W; Zimna K; Sroka Ł; Uchman P; Sajdak S
Ginekol Pol; 2002 Nov; 73(11):939-44. PubMed ID: 12722378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
